King Pharmaceuticals KG Number of securities in an unrealized loss position
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept kg:FixedSecuritiesinUnrealizedLossPositionsQualitativeDisclosureNumberofPositions.
The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's number of securities in an unrealized loss position.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is King Pharmaceuticals's number of securities in an unrealized loss position?
- King Pharmaceuticals (KG) reported number of securities in an unrealized loss position of 26 in Q1 2026.